QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Vol. 20, Issue 1, 319-327, January 1, 2009

This Article Full Text Full Text (PDF) All Versions of this Article: E08-07-0681v1 20/1/319    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cheng, F. Articles by Zagon, I. S. Search for Related Content PubMed PubMed Citation Articles by Cheng, F. Articles by Zagon, I. S.

The OGF–OGFr Axis Utilizes the p16^INK4a and p21^WAF1/CIP1 Pathways to Restrict Normal Cell Proliferation

Fan Cheng^*, Patricia J. McLaughlin^*, Michael F. Verderame, and Ian S. Zagon^*

*Department of Neural and Behavioral Sciences, and Department of Medicine, The Pennsylvania State University College of Medicine, Hershey, PA 17033

Submitted July 3, 2008; Revised September 30, 2008; Accepted October 7, 2008
Monitoring Editor: Jonathan Chernoff

Opioid growth factor (OGF) is an endogenous opioid peptide ([Met⁵]enkephalin) that interacts with the OGF receptor (OGFr) and serves as a tonically active negative growth factor in cell proliferation of normal cells. To clarify the mechanism by which OGF inhibits cell replication in normal cells, we investigated the effect of the OGF–OGFr axis on cell cycle activity in human umbilical vein endothelial cells (HUVECs) and human epidermal keratinocytes (NHEKs). OGF markedly depressed cell proliferation of both cell lines by up to 40% of sterile water controls. Peptide treatment induced cyclin-dependent kinase inhibitor (CKI) p16^INK4a protein expression and p21^WAF1/CIP1 protein expression in HUVECs and NHEKs, but had no effect on p15, p18, p19, or p27 protein expression in either cell type. Inhibition of either p16^INK4a or p21^WAF1/CIP1 activation by specific siRNAs blocked OGF inhibitory action. Human dermal fibroblasts and mesenchymal stem cells also showed a similar dependence of OGF action on p16^INK4a and p21^WAF1/CIP1. Collectively, these results indicate that both p16^INK4a and p21^WAF1/CIP1 are required for the OGF–OGFr axis to inhibit cell proliferation in normal cells.

Address correspondence to: Ian S. Zagon (isz1{at}psu.edu).

Abbreviations used: CKI, cyclin-dependent kinase inhibitor; NTX, naltrexone hydrochloride; OGF, opioid growth factor; OGFr, opioid growth factor receptor; Rb, retinoblastoma; siRNA, small interfering RNA.

This article has been cited by other articles:

				D. M. Avella, E. T. Kimchi, R. N. Donahue, H. R. S. Tagaram, P. J. McLaughlin, I. S. Zagon, and K. F. Staveley-O'Carroll The opioid growth factor-opioid growth factor receptor axis regulates cell proliferation of human hepatocellular cancer Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2010; 298(2): R459 - R466. [Abstract] [Full Text] [PDF]

				I. S. Zagon, K. A. Rahn, A. P. Turel, and P. J. McLaughlin Endogenous Opioids Regulate Expression of Experimental Autoimmune Encephalomyelitis: A New Paradigm for the Treatment of Multiple Sclerosis Exp Biol Med, November 1, 2009; 234(11): 1383 - 1392. [Abstract] [Full Text] [PDF]

				I. S. Zagon, R. N. Donahue, and P. J. McLaughlin Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2009; 297(4): R1154 - R1161. [Abstract] [Full Text] [PDF]

				F. Cheng, P. J. McLaughlin, M. F. Verderame, and I. S. Zagon Dependence on Nuclear Localization Signals of the Opioid Growth Factor Receptor in the Regulation of Cell Proliferation Exp Biol Med, May 1, 2009; 234(5): 532 - 541. [Abstract] [Full Text] [PDF]